Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells

Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a...

Full description

Bibliographic Details
Main Authors: Panpan Meng, Yi-Fan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu, Xinjun Liang, Mingqian Feng, Xiaoqing Yang, Mitchell Ho
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-79524-3
_version_ 1819202212912431104
author Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
author_facet Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
author_sort Panpan Meng
collection DOAJ
description Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a cell surface transmembrane protein (FAT1) as a new GPC3 interacting protein. The GPC3 binding region on FAT1 was initially mapped to the C-terminal region (Q14517, residues 3662-4181), which covered a putative receptor tyrosine phosphatase (RTP)-like domain, a Laminin G-like domain, and five EGF-like domains. Fine mapping by ELISA and flow cytometry showed that the last four EGF-like domains (residues 4013-4181) contained a specific GPC3 binding site, whereas the RTP domain (residues 3662-3788) and the downstream Laminin G-2nd EGF-like region (residues 3829-4050) had non-specific GPC3 binding. In support of their interaction, GPC3 and FAT1 behaved concomitantly or at a similar pattern, e.g. having elevated expression in HCC cells, being up-regulated under hypoxia conditions, and being able to regulate the expression of EMT-related genes Snail, Vimentin, and E-Cadherin and promoting HCC cell migration. Taken together, our study provides the initial evidence for the novel mechanism of GPC3 and FAT1 in promoting HCC cell migration.
first_indexed 2024-12-23T04:00:26Z
format Article
id doaj.art-329ef05cc3ff4f34a6454608732c6a4c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-23T04:00:26Z
publishDate 2021-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-329ef05cc3ff4f34a6454608732c6a4c2022-12-21T18:00:44ZengNature PortfolioScientific Reports2045-23222021-01-0111111210.1038/s41598-020-79524-3Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cellsPanpan Meng0Yi-Fan Zhang1Wangli Zhang2Xin Chen3Tong Xu4Sheng Hu5Xinjun Liang6Mingqian Feng7Xiaoqing Yang8Mitchell Ho9College of Life Science and Technology, Huazhong Agricultural UniversityLaboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of HealthCollege of Life Science and Technology, Huazhong Agricultural UniversityCollege of Life Science and Technology, Huazhong Agricultural UniversityCollege of Life Science and Technology, Huazhong Agricultural UniversityHubei Cancer HospitalHubei Cancer HospitalCollege of Biomedicine and Health, Huazhong Agricultural UniversityHospital of Huazhong Agricultural UniversityLaboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of HealthAbstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a cell surface transmembrane protein (FAT1) as a new GPC3 interacting protein. The GPC3 binding region on FAT1 was initially mapped to the C-terminal region (Q14517, residues 3662-4181), which covered a putative receptor tyrosine phosphatase (RTP)-like domain, a Laminin G-like domain, and five EGF-like domains. Fine mapping by ELISA and flow cytometry showed that the last four EGF-like domains (residues 4013-4181) contained a specific GPC3 binding site, whereas the RTP domain (residues 3662-3788) and the downstream Laminin G-2nd EGF-like region (residues 3829-4050) had non-specific GPC3 binding. In support of their interaction, GPC3 and FAT1 behaved concomitantly or at a similar pattern, e.g. having elevated expression in HCC cells, being up-regulated under hypoxia conditions, and being able to regulate the expression of EMT-related genes Snail, Vimentin, and E-Cadherin and promoting HCC cell migration. Taken together, our study provides the initial evidence for the novel mechanism of GPC3 and FAT1 in promoting HCC cell migration.https://doi.org/10.1038/s41598-020-79524-3
spellingShingle Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
Scientific Reports
title Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_full Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_fullStr Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_full_unstemmed Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_short Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_sort identification of the atypical cadherin fat1 as a novel glypican 3 interacting protein in liver cancer cells
url https://doi.org/10.1038/s41598-020-79524-3
work_keys_str_mv AT panpanmeng identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT yifanzhang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT wanglizhang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xinchen identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT tongxu identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT shenghu identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xinjunliang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT mingqianfeng identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xiaoqingyang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT mitchellho identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells